These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38277422)

  • 1. Preferences and decisional considerations relating to opioid agonist therapy among Ukrainian people who use drugs: A conjoint analysis survey.
    Bromberg DJ; Madden LM; Fraenkel L; Muthulingam D; Rhoades D; Dvoriak S; Dumchev K; Pykalo I; Altice FL
    PLOS Glob Public Health; 2024; 4(1):e0002725. PubMed ID: 38277422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Willingness to pay for opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
    Makarenko I; Mazhnaya A; Marcus R; Bojko MJ; Madden L; Filippovich S; Dvoriak S; Altice FL
    Int J Drug Policy; 2017 Jul; 45():56-63. PubMed ID: 28628853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: dynamic modeling analysis.
    Morozova O; Crawford FW; Cohen T; Paltiel AD; Altice FL
    Addiction; 2020 Mar; 115(3):437-450. PubMed ID: 31478285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferences in medications for patients seeking treatment for opioid use disorder: A conjoint analysis.
    Muthulingam D; Hassett TC; Madden LM; Bromberg DJ; Fraenkel L; Altice FL
    J Subst Use Addict Treat; 2023 Nov; 154():209138. PubMed ID: 37544510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with physical and sexual violence by police among people who inject drugs in Ukraine: implications for retention on opioid agonist therapy.
    Kutsa O; Marcus R; Bojko MJ; Zelenev A; Mazhnaya A; Dvoriak S; Filippovych S; Altice FL
    J Int AIDS Soc; 2016; 19(4 Suppl 3):20897. PubMed ID: 27435717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of expanding opioid agonist therapies on the HIV epidemic and mortality in Ukraine: a modelling study.
    Tan J; Altice FL; Madden LM; Zelenev A
    Lancet HIV; 2020 Feb; 7(2):e121-e128. PubMed ID: 31879250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the Russian invasion on opioid agonist therapy programs in Ukraine: A qualitative study.
    Dubov A; Basenko A; Dymaretskyi O; Shoptaw S
    Drug Alcohol Depend; 2024 Feb; 255():111069. PubMed ID: 38159338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient preferences and extended-release naltrexone: A new opportunity to treat opioid use disorders in Ukraine.
    Marcus R; Makarenko I; Mazhnaya A; Zelenev A; Polonsky M; Madden L; Filippovych S; Dvoriak S; Springer SA; Altice FL
    Drug Alcohol Depend; 2017 Oct; 179():213-219. PubMed ID: 28806638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of barrier severity and willingness to enter opioid agonist treatment among people who inject drugs in Ukraine.
    Zelenev A; Shea P; Mazhnaya A; Rozanova J; Madden L; Marcus R; Altice FL
    Drug Alcohol Depend; 2018 Sep; 190():82-88. PubMed ID: 29990648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A qualitative assessment of attitudes about and preferences for extended-release naltrexone, a new pharmacotherapy to treat opioid use disorders in Ukraine.
    Marcus R; Bojko MJ; Mazhnaya A; Makarenko I; Filippovych S; Dvoriak S; Altice FL; Springer SA
    J Subst Abuse Treat; 2018 Mar; 86():86-93. PubMed ID: 29415856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment.
    Bojko MJ; Mazhnaya A; Marcus R; Makarenko I; Islam Z; Filippovych S; Dvoriak S; Altice FL
    J Subst Abuse Treat; 2016 Jul; 66():37-47. PubMed ID: 27211995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary healthcare-based integrated care with opioid agonist treatment: First experience from Ukraine.
    Morozova O; Dvoriak S; Pykalo I; Altice FL
    Drug Alcohol Depend; 2017 Apr; 173():132-138. PubMed ID: 28242537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The real-world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine.
    Farnum SO; Makarenko I; Madden L; Mazhnaya A; Marcus R; Prokhorova T; Bojko MJ; Rozanova J; Dvoriak S; Islam Z; Altice FL
    Addiction; 2021 Jan; 116(1):83-93. PubMed ID: 32428276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid Agonist Treatment and Improved Outcomes at Each Stage of the HIV Treatment Cascade in People Who Inject Drugs in Ukraine.
    Mazhnaya A; Marcus R; Bojko MJ; Zelenev A; Makarenko I; Pykalo I; Filippovych S; Dvoriak S; Altice FL
    J Acquir Immune Defic Syndr; 2018 Nov; 79(3):288-295. PubMed ID: 30312275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
    Makarenko I; Mazhnaya A; Polonsky M; Marcus R; Bojko MJ; Filippovych S; Springer S; Dvoriak S; Altice FL
    Drug Alcohol Depend; 2016 Aug; 165():213-20. PubMed ID: 27370527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine.
    Machavariani E; Dumchev K; Pykalo I; Filippovych M; Ivasiy R; Esserman D; Madden LM; Bromberg DJ; Haddad M; Morozova O; Ahmad B; Gómez DO; Farnum SO; Dvoriak S; Altice FL
    Contemp Clin Trials; 2024 Sep; 146():107690. PubMed ID: 39265780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users.
    Shrestha R; Karki P; Altice FL; Dubov O; Fraenkel L; Huedo-Medina T; Copenhaver M
    AIDS Behav; 2018 Apr; 22(4):1228-1238. PubMed ID: 28695388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-examining provider perceptions of best pre-war practices: what elements can help opiate agonist therapy programs in Ukraine successfully survive the crisis?
    Dellamura P; Meteliuk A; Fomenko T; Rozanova J
    Front Public Health; 2023; 11():1259488. PubMed ID: 38239802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: a three-setting analysis.
    Stone J; Degenhardt L; Grebely J; Larney S; Altice FL; Smyrnov P; Rahimi-Movaghar A; Alavi M; Young AM; Havens JR; Miller WC; Hickman M; Vickerman P
    Lancet Psychiatry; 2021 Apr; 8(4):301-309. PubMed ID: 33640039
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.